(PharmaNewsWire.Com, June 05, 2017 ) VADs are of three types — LVADs, BiVADs, and RVADs — that are used to treat heart failure. VADs help the weakened heart to pump blood for circulation to other body organs. Surgeons implant these mechanical devices as a treatment option for severe heart conditions such as acute or chronic cardiac functional deterioration and heart failure.
Publisher's analysts forecast the global ventricular assist devices (VADs) market to grow at a CAGR of 12.04% during the period 2016-2020. For more information about this report: http://www.reportsweb.com/global-ventricular-assist-devices-market-2016-2020 Covered in this report The report covers the present scenario and the growth prospects of the global ventricular assist devices (VADs) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of different VADs. They are left ventricular assist devices, biventricular assist devices, and right ventricular assist devices.
The market is divided into the following segments based on geography: - Americas - APAC - EMEA
Publisher's report, Global Ventricular Assist Devices (VADs) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors - ABIOMED - Berlin Heart - HeartWare - St. Jude Medical
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: